Latest Asset Management News

Regal Partners anticipates a strong 2025 with normalised NPAT reaching $145 million, propelled by a significant jump in performance fees and funds under management climbing to $20.8 billion.

InhaleRx Limited has completed the final tranche of its share placement, raising $600,000 to support its clinical-stage drug development programs targeting pain and mental health.

CD Private Equity Fund II has completed a full exit from a key underlying investment, generating robust returns and preparing to distribute proceeds to unitholders in early 2026.

Environmental Clean Technologies Limited has completed its acquisition of Terrajoule Pty Ltd, securing exclusive rights to innovative soil remediation technology, while raising $3.25 million to fuel its growth and advancing promising fertiliser trials.

InhaleRx Limited has successfully closed its entitlement offer and placement, raising $857,730 to support the clinical development of inhaled treatments targeting cancer pain and mental health conditions.

Wingara AG Limited has arranged a $250,000 unsecured loan facility from NAOS Asset Management entities, featuring a convertible note option that could reshape its capital structure.

Income Asset Management has secured a $2 million unsecured debt facility at 15% interest to strengthen liquidity during the quieter Christmas period while awaiting insurance claim outcomes related to a recent fraud event.

FlexiRoam has secured a strategic partnership with Generali Insurance Malaysia to deploy its AI-driven eSIM connectivity platform through WhatsApp, targeting the growing travel insurance market.

RemSense Technologies has secured a follow-up contract with ExxonMobil to deliver advanced digital twin solutions at the Bass Strait facility, reinforcing its role in the energy sector’s digital transformation.

Triton Minerals reports encouraging geological signs from its maiden drilling at the Aucu Gold-Copper Project despite operational hurdles, while legal delays stall the completion of its 70% graphite asset sale.

Biotron Limited has closed its non-renounceable rights issue, raising $645,861 to advance its Hepatitis B virus drug development, with a shortfall commitment from Peak Asset Management still pending.

Qube Holdings has confirmed that Macquarie Asset Management has met the conditions to extend their exclusivity period, keeping potential deal talks alive but without any guarantee of a binding agreement.